Nonoperating Income (Expense) in USD of CITIUS ONCOLOGY, INC. from 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CITIUS ONCOLOGY, INC. quarterly/annual Nonoperating Income (Expense) history and change rate from 2022 to Q2 2024.
  • CITIUS ONCOLOGY, INC. Nonoperating Income (Expense) for the quarter ending 30 Jun 2024 was $636K, a 22% decline year-over-year.
  • CITIUS ONCOLOGY, INC. Nonoperating Income (Expense) for the twelve months ending 30 Jun 2024 was $3.25M.
  • CITIUS ONCOLOGY, INC. annual Nonoperating Income (Expense) for 2023 was $3.43M, a 561% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.25M $636K -$179K -22% 01 Apr 2024 30 Jun 2024 10-Q 09 Aug 2024
Q1 2024 $3.43M $758K -$1.39K -0.18% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $3.43M $1.28M 01 Oct 2023 31 Dec 2023 10-K 16 Apr 2024
Q3 2023 $579K 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 $816K 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 $760K 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024

CITIUS ONCOLOGY, INC. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.43M +$2.91M +561% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024
2022 $519K 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.